YILI(SH:600887) Xin Hua Wang·2025-10-16 14:06Core Viewpoint - The infant formula industry is undergoing a transformation, with leading brands like Jinlingguan redefining the value of "Chinese solutions" in the global maternal and infant nutrition sector through scientific innovation and industrial achievement [1][3]. Group 1: Product Innovation - On October 16, the global product launch event for Yili Jinlingguan was held in Jiayuguan, showcasing a series of products based on HMO milk source patent applications and sharing new findings from Yili's breast milk research [3][11]. - Jinlingguan announced the reformulation of two products, Jinlingguan Zhenhu Platinum and Zhenhu, and introduced two new products, Zhenhu Chunrui and Zhenhu Yuanchu, aimed at providing more professional and scientific nutritional support for Chinese babies [7][11]. - The upgraded Jinlingguan Zhenhu Platinum focuses on six-dimensional comprehensive nutrition, incorporating high levels of lactoferrin, super OPO, and 18 active brain nutrients to enhance protection, absorption, cognition, gut vitality, bone strength, and sensitivity [7][10]. Group 2: Research and Development - Jinlingguan has established a global six-in-one research strategy in maternal milk studies, focusing on absorption, immunity, gut health, brain development, bone development, and low allergenicity [5][11]. - Yili has accumulated over 10 million data points on breast milk components, creating the first "breast milk research database" among Chinese dairy companies and completing over 290 invention patents [10][11]. - The company is accelerating the transformation from laboratory research to industrial practice, expanding from single-element breakthroughs to system simulations, and elevating the value from "Chinese solutions" to global consensus [11].